Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Elben

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Brain : a Journal of Neurology|December 28, 2020
Reference values for the Cerebellar Cognitive Affective Syndrome Scale: age and education matterAndreas Thieme, Sandra Röske, Jennifer Faber, et al.
Frontiers in Human Neuroscience|December 16, 2024
The population based cognitive testing in subjects with SARS-CoV-2 (POPCOV2) study: longitudinal investigation of remote cognitive and fatigue screening in PCR-positive cases and negative controlsAlina von Etzdorf, Maja Harzen, Hannah Heinrichs, et al.
Psychiatry Research|July 31, 2023
Cognitive and neuropsychiatric trajectories up to one year after mild to severe COVID-19Ana S Costa, Carolin Balloff, Julia Bungenberg, et al.
Neurological Research and Practice|December 16, 2020
Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocolAndreas Thieme, Sandra Roeske, Jennifer Faber, et al.
Journal of Neurology|April 2, 2022
The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patientsAndreas Thieme, Jennifer Faber, Patricia Sulzer, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Clinical Neurology and Neurosurgery|December 22, 2022
Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapyChristoph Mueller, Saskia Elben, Gregory S Day, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
Scientific Reports|November 10, 2023
Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessmentsCarolin Balloff, Carolina Bandlow, Michael Bernhard, et al.
Journal of Neurology|April 17, 2025
Optimizing selectivity of the Cerebellar Cognitive Affective Syndrome Scale by use of correction formulas, and validation of its German versionAndreas Thieme, Kerstin Rubarth, Raquel van der Veen, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Brain : a Journal of Neurology|December 28, 2020
Reference values for the Cerebellar Cognitive Affective Syndrome Scale: age and education matterAndreas Thieme, Sandra Röske, Jennifer Faber, et al.
Frontiers in Human Neuroscience|December 16, 2024
The population based cognitive testing in subjects with SARS-CoV-2 (POPCOV2) study: longitudinal investigation of remote cognitive and fatigue screening in PCR-positive cases and negative controlsAlina von Etzdorf, Maja Harzen, Hannah Heinrichs, et al.
Psychiatry Research|July 31, 2023
Cognitive and neuropsychiatric trajectories up to one year after mild to severe COVID-19Ana S Costa, Carolin Balloff, Julia Bungenberg, et al.
Neurological Research and Practice|December 16, 2020
Validation of a German version of the Cerebellar Cognitive Affective/ Schmahmann Syndrome Scale: preliminary version and study protocolAndreas Thieme, Sandra Roeske, Jennifer Faber, et al.
Journal of Neurology|April 2, 2022
The CCAS-scale in hereditary ataxias: helpful on the group level, particularly in SCA3, but limited in individual patientsAndreas Thieme, Jennifer Faber, Patricia Sulzer, et al.
Cells|April 11, 2025
Effects of Anti-CD20 Antibody Therapy on Immune Cell Dynamics in Relapsing-Remitting Multiple SclerosisAlice G Willison, Ramona Hagler, Margit Weise, et al.
Clinical Neurology and Neurosurgery|December 22, 2022
Review and meta-analysis of neuropsychological findings in autoimmune limbic encephalitis with autoantibodies against LGI1, CASPR2, and GAD65 and their response to immunotherapyChristoph Mueller, Saskia Elben, Gregory S Day, et al.
Frontiers in Immunology|May 20, 2021
Case Report: Convalescent Plasma Achieves SARS-CoV-2 Viral Clearance in a Patient With Persistently High Viral Replication Over 8 Weeks Due to Severe Combined Immunodeficiency (SCID) and Graft FailureVerena Keitel, Johannes Georg Bode, Torsten Feldt, et al.
Scientific Reports|November 10, 2023
Prevalence and prognostic value of neurological affections in hospitalized patients with moderate to severe COVID-19 based on objective assessmentsCarolin Balloff, Carolina Bandlow, Michael Bernhard, et al.
Journal of Neurology|April 17, 2025
Optimizing selectivity of the Cerebellar Cognitive Affective Syndrome Scale by use of correction formulas, and validation of its German versionAndreas Thieme, Kerstin Rubarth, Raquel van der Veen, et al.
Pageof 6